Today: 7 February 2026
Subscribe
Browse Category

SGX:G13.SI News 10 December 2025 - 14 January 2026

Genting Singapore (G13.SI) Share Price, Latest News and 2026 Stock Forecast After Moody’s Downgrade

Genting Singapore (G13.SI) Share Price, Latest News and 2026 Stock Forecast After Moody’s Downgrade

SINGAPORE – 10 December 2025 – Genting Singapore Limited, the operator of Resorts World Sentosa and one of the Straits Times Index’s most watched consumer names, is back in the spotlight after a fresh credit rating downgrade at group level – even as earnings recover, tourism rebounds and analysts project double‑digit upside for the stock. Genting Singapore share price today: trading around S$0.73 Genting Singapore’s share price is trading in the low‑70 Singapore cents range on 10 December 2025. SGinvestors quotes the counter at S$0.735 as of 14:28 SGT, while Beansprout shows S$0.725 earlier in the session, implying modest intraday
10 December 2025
·

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop